Watch NMHIW. Know when insiders buy.
One email the day a filing lands. Free.
NMHIW
Nature's Miracle Holding Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $677K −91.7%NET INCOME −$7.1MNET DEBT $26K52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $42K | −96.2% | 7.0% | −$1.1M | $2.8M | — | 0.01 | −$1.6M | $1M | −$2.6M | May 27 |
| Q4 2025 · Dec 31derived | $79K | −86.8% | -828.4% | −$3.5M | −$6M | — | 0.01 | −$2.2M | — | — | Apr 15 |
| Q3 2025 · Sep 30 | $72K | −97.6% | 0.6% | −$1.3M | −$2.2M | — | -0.20 | −$896K | — | — | Apr 14 |
| Q2 2025 · Jun 30 | $484K | −85.8% | 6.0% | −$1.2M | −$1.8M | — | -0.29 | −$315K | — | — | Apr 14 |
| Q1 2025 · Mar 31 | $1.1M | −49.8% | 15.8% | −$1.2M | −$2M | — | -0.43 | −$594K | — | — | May 27 |
| Q4 2024 · Dec 31derived | $599K | −55.0% | -633.9% | −$6.1M | −$6.8M | — | -4.19 | −$2.8M | — | — | Apr 15 |
| Q3 2024 · Sep 30 | $3.1M | +13.5% | 7.5% | −$2M | −$2.8M | — | -2.73 | −$1.4M | — | — | Apr 14 |
| Q2 2024 · Jun 30 | $3.4M | +75.2% | 13.3% | −$1.3M | −$1.8M | — | -2.01 | −$969K | — | — | Apr 14 |
| Q1 2024 · Mar 31 | $2.2M | — | 14.2% | −$1M | −$2.3M | — | -2.99 | −$773K | — | — | Apr 14 |
| Q4 2023 · Dec 31derived | $1.3M | — | -113.0% | −$5M | −$6M | — | -9.82 | −$863K | — | — | Apr 16 |
| Q3 2023 · Sep 30 | $2.7M | — | 5.9% | −$421K | −$404K | — | -0.02 | −$320K | — | — | Nov 14 |
| Q2 2023 · Jun 30 | $1.9M | — | 5.2% | −$358K | −$407K | — | -0.02 | −$63K | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.7M | -25.9% | −$7.2M | −$12M | -688.0% | -0.81 | −$4M | — | — | — | — |
| FY2024 · to Dec 31 | $9.3M | -30.3% | −$10.3M | −$13.7M | -147.4% | -11.88 | −$5.9M | — | — | — | — |
| FY2023 · to Dec 31 | $8.9M | -10.6% | −$6M | −$7.3M | -82.1% | -9.88 | −$1.7M | — | — | — | — |
| FY2022 · to Dec 31 | $18.6M | 9.0% | −$1.8M | −$2.5M | -13.2% | -0.15 | −$2.5M | $53K | −$2.5M | — | — |
Every number comes from Nature's Miracle Holding Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.